| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |